GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaron Beijing Co Ltd (STU:17Q1) » Definitions » Common Stock

Pharmaron Beijing Co (STU:17Q1) Common Stock : €233 Mil (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Pharmaron Beijing Co Common Stock?

Pharmaron Beijing Co's quarterly common stock declined from Jun. 2024 (€229 Mil) to Sep. 2024 (€228 Mil) but then increased from Sep. 2024 (€228 Mil) to Dec. 2024 (€233 Mil).

Pharmaron Beijing Co's annual common stock increased from Dec. 2022 (€161 Mil) to Dec. 2023 (€230 Mil) and increased from Dec. 2023 (€230 Mil) to Dec. 2024 (€233 Mil).


Pharmaron Beijing Co Common Stock Historical Data

The historical data trend for Pharmaron Beijing Co's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaron Beijing Co Common Stock Chart

Pharmaron Beijing Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.86 110.35 161.30 229.55 233.24

Pharmaron Beijing Co Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 229.55 228.34 228.89 227.59 233.24

Pharmaron Beijing Co Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Pharmaron Beijing Co Business Description

Traded in Other Exchanges
Address
No. 248 Queen’s Road East, 40th Floor, Dah Sing Financial Centre, Wanchai, Hong Kong, HKG
Pharmaron Beijing Co Ltd is a research and development service company supporting the life science industry. The company offers drug research and development service capabilities, ranging from synthetic, medicinal, and analytical chemistry, biology, DMPK, pharmacology, drug safety assessment, radiochemistry and isotopically labelled metabolism, chemical and pharmaceutical development to clinical development. The company's operating segment includes Laboratory services; CMC (small molecule CDMO) services; Clinical development services and biologics and CGT services. It generates maximum revenue from the Laboratory services segment.

Pharmaron Beijing Co Headlines

No Headlines